某三甲医院急性冠脉综合征患者LDL-C控制情况的调查

Survey of LDL-C control in patients with acute coronary syndrome in a 3A Grade Hospital

目的调查某院急性冠脉综合征(ACS)患者发病后6个月的低密度脂蛋白(LDL-C)控制情况,为临床药师参与这类患者的管理提供参考。方法筛选2017年9月~2018年6月某院收治且后续在该院规律复诊的ACS患者共73例,回顾性分析其6个月的LDL-C控制情况。结果78.1%的患者3个月内至少有监测1次LDL-C,达标率28.1%;21.9%的患者在出院后4~6个月才首次监测LDL-C,4~6个月共计28例患者监测LDL-C,达标率为25%。35.6%的患者出院时处方高强度他汀,64.4%的患者出院时处方中等强度他汀。结论某院对ACS患者的血脂监测周期有待进一步规范,LDL-C达标率有待进一步提高,临床药师应积极参与此类患者的管理。

Objective To investigate the low-density lipoprotein(LDL-C)control in patients with acute coronary syndrome,and provide a reference for clinical pharmacists to participate in the management of such patients.Methods A total of 73 patients with ACS who received treatment in our hospital from September 2017 to June 2018 and followed up with regular follow-up visits in our hospital were screened and retrospectively analyzed their LDL-C control for 6 months.Results 78.1%of the patients had been monitored LDL-C at least once within three months,the goal attainment rates were 28.1%;21.9%of the patients had their first monitoring of LDL-C in 4 to 6 months after ACS onset,and 28 patients had been monitored LDL-C,the goal attainment rates were 25%.35.6%of patients were prescribed with high-intensity statins and 64.4%with moderate-intensity statins.Conclusion The blood lipid monitoring cycle of patients with ACS in our hospital needs to be further standardized,and the LDL-C goal attainment rates needs to be further improved.Clinical pharmacists should actively participate in the management of such patients.